You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Product Overview

Zyban (Bupropion Hydrochloride) for use as an aid to smoking cessation in nicotine-dependent patients in combination with motivational support.

Resource

Encourage patient adherence by downloading the Zyban ‘Quit Buddy’ today. Help keep patients stay motivated to quit smoking. Includes ‘How to take Zyban’, progress calendar and ‘Top tips for Quitting’.

Adverse events should be reported to the Health Products Regulatory Authority (HPRA) using an Adverse Reaction Report Form obtained either from the HPRA or electronically via the website at www.hpra.ie. Adverse reactions can also be reported to the HPRA by calling (01 6764971). Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

Zyban is a registered trademark of the GlaxoSmithKline group of companies